Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Oncotargets and Therapy|January 27, 2016
Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitorWenxian Wang, Xiaowen Jiang, Zhengbo Song, et al.
Scientific Reports|November 7, 2024
Research on time-varying path optimization for multi-vehicle type fresh food logistics distribution considering energy consumptionHao Chen, Wenxian Wang, Li Jia, et al.
Molecular and Clinical Oncology|February 19, 2021
Baseline anemia and anemia grade are independent prognostic factors for stage IV non-small cell lung cancerCheng Chen, Zhengbo Song, Wenxian Wang, et al.
Oncotargets and Therapy|October 17, 2019
The efficacy and safety of anlotinib treatment for advanced lung cancerLan Shao, Wenxian Wang, Zhengbo Song, et al.
Scientific Reports|February 20, 2024
A cooperative optimization method for the layout of shared bicycle parking areas and delivery quantityHao Chen, Wenxian Wang, Ligang Cheng, et al.
Lung Cancer (Amsterdam, Netherlands)|June 25, 2020
Evaluation of a new diagnostic immunohistochemistry approach for ROS1 rearrangement in non-small cell lung cancerWenxian Wang, Guoping Cheng, Gu Zhang, et al.
Frontiers in Psychology|February 21, 2022
Servant Leadership and Creativity: A Study of the Sequential Mediating Roles of Psychological Safety and Employee Well-BeingWenxian Wang, Seung-Wan Kang, Suk Bong Choi
International Journal of Environmental Research and Public Health|October 23, 2021
Effects of Employee Well-Being and Self-Efficacy on the Relationship between Coaching Leadership and Knowledge Sharing Intention: A Study of UK and US EmployeesWenxian Wang, Seung-Wan Kang, Suk Bong Choi
Cellular Signalling|May 21, 2011
Protein kinase C epsilon affects mitochondrial function through estrogen-related receptor alphaNa Lu, Wenxian Wang, Jinsong Liu, et al.
Annals of Palliative Medicine|January 12, 2022
Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)Jinfei Si, Xiaodong Gu, Wenxian Wang, et al.
Pageof 17